These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 18364618

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
    Khan AA, Sándor GK, Dore E, Morrison AD, Alsahli M, Amin F, Peters E, Hanley DA, Chaudry SR, Dempster DW, Glorieux FH, Neville AJ, Talwar RM, Clokie CM, Al Mardini M, Paul T, Khosla S, Josse RG, Sutherland S, Lam DK, Carmichael RP, Blanas N, Kendler D, Petak S, St-Marie LG, Brown J, Evans AW, Rios L, Compston JE, Canadian Association of Oral and Maxillofacial Surgeons.
    J Rheumatol; 2008 Jul; 35(7):1391-7. PubMed ID: 18528958
    [Abstract] [Full Text] [Related]

  • 3. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P.
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [Abstract] [Full Text] [Related]

  • 4. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.
    Rizzoli R, Burlet N, Cahall D, Delmas PD, Eriksen EF, Felsenberg D, Grbic J, Jontell M, Landesberg R, Laslop A, Wollenhaupt M, Papapoulos S, Sezer O, Sprafka M, Reginster JY.
    Bone; 2008 May; 42(5):841-7. PubMed ID: 18314405
    [Abstract] [Full Text] [Related]

  • 5. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
    King AE, Umland EM.
    Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Bisphosphonates and osteonecrosis of the jaws].
    Urade M.
    Clin Calcium; 2007 Feb; 17(2):241-8. PubMed ID: 17272882
    [Abstract] [Full Text] [Related]

  • 8. Bisphosphonate associated osteonecrosis of the jaw.
    Khan AA, Sándor GK, Dore E, Morrison AD, Alsahli M, Amin F, Peters E, Hanley DA, Chaudry SR, Lentle B, Dempster DW, Glorieux FH, Neville AJ, Talwar RM, Clokie CM, Mardini MA, Paul T, Khosla S, Josse RG, Sutherland S, Lam DK, Carmichael RP, Blanas N, Kendler D, Petak S, Ste-Marie LG, Brown J, Evans AW, Rios L, Compston JE, Canadian Taskforce on Osteonecrosis of the Jaw.
    J Rheumatol; 2009 Mar; 36(3):478-90. PubMed ID: 19286860
    [Abstract] [Full Text] [Related]

  • 9. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
    Marx RE, Sawatari Y, Fortin M, Broumand V.
    J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients--May 2006.
    Weitzman R, Sauter N, Eriksen EF, Tarassoff PG, Lacerna LV, Dias R, Altmeyer A, Csermak-Renner K, McGrath L, Lantwicki L, Hohneker JA.
    Crit Rev Oncol Hematol; 2007 May; 62(2):148-52. PubMed ID: 17336086
    [Abstract] [Full Text] [Related]

  • 13. Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment.
    Dickinson M, Prince HM, Kirsa S, Zannettino A, Gibbs SD, Mileshkin L, O'Grady J, Seymour JF, Szer J, Horvath N, Joshua DE.
    Intern Med J; 2009 May; 39(5):304-16. PubMed ID: 19220531
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment.
    Fehm T, Felsenberg D, Krimmel M, Solomayer E, Wallwiener D, Hadjii P.
    Breast; 2009 Aug; 18(4):213-7. PubMed ID: 19651512
    [Abstract] [Full Text] [Related]

  • 16. Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management.
    Ruggiero SL, Mehrotra B.
    Annu Rev Med; 2009 Aug; 60():85-96. PubMed ID: 18928335
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [New development in bisphosphonate treatment. Bisphosphonate therapy and osteonecrosis of the jaws].
    Urade M.
    Clin Calcium; 2009 Jan; 19(1):100-8. PubMed ID: 19122270
    [Abstract] [Full Text] [Related]

  • 19. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
    Siddiqi A, Payne AG, Zafar S.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e1-8. PubMed ID: 19570696
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.